デフォルト表紙
市場調査レポート
商品コード
1585615

生体電気医学市場:製品タイプ、適応症、エンドユーザー別-2025-2030年の世界予測

Bioelectric Medicine Market by Product (Cardiac Pacemakers, Cochlear Implants, Deep Brain Stimulators), Type (Implantable Electroceutical Devices, Noninvasive Electroceutical Devices), Indication, End-User - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 183 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
生体電気医学市場:製品タイプ、適応症、エンドユーザー別-2025-2030年の世界予測
出版日: 2024年10月31日
発行: 360iResearch
ページ情報: 英文 183 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

生体電気医学市場は、2023年に238億3,000万米ドルと評価され、2024年には267億4,000万米ドルに達すると予測され、CAGR 12.29%で成長し、2030年には536億6,000万米ドルに達すると予測されています。

生体電気医学は、生体工学、神経学、先端医療技術が交差する急成長分野であり、電気インパルスを利用して神経系の活動を治療目的で調節します。その範囲は、慢性疼痛、てんかん、うつ病、炎症性疾患などのさまざまな症状を治療するために、特定の神経経路をターゲットとした埋め込み型および非侵襲性のデバイスを開発することです。生体電気医学の必要性は、副作用や有効性に限界があることが多い薬理学的治療に代わる、あるいは補完的な解決策を提供する可能性にあります。治療主は循環器科、神経科、疼痛管理に及び、最終用途には病院、専門クリニック、在宅医療が含まれます。

主な市場の統計
基準年[2023] 238億3,000万米ドル
予測年[2024] 267億4,000万米ドル
予測年[2030] 536億6,000万米ドル
CAGR(%) 12.29%

生体電気医学市場の主な成長要因としては、慢性疾患の有病率の上昇、神経調節技術の発展、研究開発投資の増加などが挙げられます。ヘルスケアシステムが世界的に効率化を求める中、生体電気医学は費用対効果の高い標的療法を提供し、需要を促進しています。ウェアラブル・バイオエレクトロニクス機器や個別化された治療プロトコルの範囲を拡大することに潜在的な治療機会があります。小型化されたエネルギー効率の高いデバイスの開発や、精密治療のための人工知能の活用には、技術革新の大きな余地があります。バイオメディカル企業と学術機関のコラボレーションはブレークスルーを促進し、規制機関が医療機器の承認経路を洗練させることで市場参入が加速する可能性があります。

しかし、市場開拓の課題は、高い開発コスト、複雑な規制の枠組み、有効性と安全性を立証するための大規模な臨床試験の必要性です。償還の問題や認知度の低さもハードルとなっています。これらの課題を克服するために、企業は包括的な臨床エビデンスの創出と積極的な利害関係者の関与に注力すべきです。生体電気治療の利点についての認識を高めるための教育キャンペーンに投資すれば、採用を促進できると思われます。結局のところ、生体電気医学におけるイノベーションは、複数の領域にわたる治療戦略を劇的に再形成する可能性があり、この分野の潜在能力を最大限に引き出し、競争上の優位性を維持するためには、継続的な研究開発が必要であることを強調しています。障壁を克服し、新たな機会を捉えるためには、共同研究、規制当局への対応、戦略的マーケティングが極めて重要となります。

市場力学:急速に進化する生体電気医学市場における主要市場インサイトの解明

生体電気医学市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 人口の慢性疾患頻度の増加
    • 新興経済諸国におけるヘルスケア分野のインフラ支出の増加
    • 高齢化社会におけるパーキンソン病の増加
  • 市場抑制要因
    • 生体電気医療機器の製造に伴う高コスト
  • 市場機会
    • 新規開発における高度な技術革新生体電気医学
    • 生体電気医薬品の規制認可率の上昇
  • 市場の課題
    • 医療機器の開発・製造に関する政府の厳しい規則や規制

ポーターの5つの力:生体電気医学市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:生体電気医学市場における外部からの影響の把握

外部マクロ環境要因は、生体電気医学市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析生体電気医学市場における競合情勢の把握

生体電気医学市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス生体電気医学市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、生体電気医学市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨生体電気医学市場における成功への道筋を描く

生体電気医学市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報に基づいた意思決定を行う上で役立つ重要な質問にも回答しています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 人口における慢性疾患の増加
      • 新興経済諸国におけるヘルスケア分野のインフラ支出の増加
      • 高齢化社会におけるパーキンソン病の発症率の上昇
    • 抑制要因
      • 生体電気医療機器の製造に関連する高コスト
    • 機会
      • 新規開発における先進的なイノベーション生体電気医学
      • バイオエレクトリック医薬品の規制承認率の上昇
    • 課題
      • 医療機器の開発と製造に関する政府の厳しい規則と規制
  • 市場セグメンテーション分析
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 生体電気医学市場:製品別

  • 心臓ペースメーカー
  • 人工内耳
  • 脳深部刺激装置
  • 植込み型除細動器
  • 仙骨神経刺激装置
  • 脊髄刺激装置
  • 経皮的電気神経刺激装置
  • 迷走神経刺激装置

第7章 生体電気医学市場:タイプ別

  • 埋め込み型電気医薬品
  • 非侵襲性電気薬理学機器

第8章 生体電気医学市場適応症別

  • 不整脈
  • 慢性疼痛
  • うつ
  • てんかん
  • パーキンソン病
  • 震え
  • 尿失禁および便失禁

第9章 生体電気医学市場:エンドユーザー別

  • 病院
  • 医薬品調査

第10章 南北アメリカの生体電気医学市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の生体電気医学市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの生体電気医学市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
  • 戦略分析と提言

企業一覧

  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • BioMed Central Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • CEFALY Technology sprl
  • ElectroCore, Inc.
  • General Electric Company
  • LivaNova PLC
  • MED-EL Elektromedizinische Gerate Gesellschaft m.b.H.
  • Medtronic PLC
  • NeuroSigma, Inc.
  • Nevro Corp.
  • Oticon Medical A/S by Cochlear Ltd
  • Renishaw PLC
  • ReShape Lifesciences, Inc.
  • Siemens Healthineers AG
  • Sonova Holding AG
  • Vomaris Innovations, Inc.
図表

LIST OF FIGURES

  • FIGURE 1. BIOELECTRIC MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 2. BIOELECTRIC MEDICINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BIOELECTRIC MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS BIOELECTRIC MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES BIOELECTRIC MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES BIOELECTRIC MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BIOELECTRIC MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC BIOELECTRIC MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOELECTRIC MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOELECTRIC MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. BIOELECTRIC MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. BIOELECTRIC MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOELECTRIC MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOELECTRIC MEDICINE MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY CARDIAC PACEMAKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY COCHLEAR IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY SACRAL NERVE STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY SPINAL CORD STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY IMPLANTABLE ELECTROCEUTICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY NONINVASIVE ELECTROCEUTICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY ARRHYTHMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY DEPRESSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY TREMOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIOELECTRIC MEDICINE MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS BIOELECTRIC MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES BIOELECTRIC MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC BIOELECTRIC MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. JAPAN BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. MALAYSIA BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. MALAYSIA BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. PHILIPPINES BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. PHILIPPINES BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SINGAPORE BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SINGAPORE BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SOUTH KOREA BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. SOUTH KOREA BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. TAIWAN BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. TAIWAN BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. THAILAND BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. THAILAND BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. VIETNAM BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. VIETNAM BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA BIOELECTRIC MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. DENMARK BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. DENMARK BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. EGYPT BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. EGYPT BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. FINLAND BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. FINLAND BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. FRANCE BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. FRANCE BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. GERMANY BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. GERMANY BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. ISRAEL BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. ISRAEL BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. ITALY BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. ITALY BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NETHERLANDS BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NETHERLANDS BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. NIGERIA BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. NIGERIA BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. NORWAY BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 153. NORWAY BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. POLAND BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 157. POLAND BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. QATAR BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 161. QATAR BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. RUSSIA BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 165. RUSSIA BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SAUDI ARABIA BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SAUDI ARABIA BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH AFRICA BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH AFRICA BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SPAIN BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SPAIN BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SWEDEN BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 181. SWEDEN BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. SWITZERLAND BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 185. SWITZERLAND BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. TURKEY BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. TURKEY BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED ARAB EMIRATES BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED ARAB EMIRATES BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM BIOELECTRIC MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED KINGDOM BIOELECTRIC MEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED KINGDOM BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. BIOELECTRIC MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 199. BIOELECTRIC MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-ED54C46E848E

The Bioelectric Medicine Market was valued at USD 23.83 billion in 2023, expected to reach USD 26.74 billion in 2024, and is projected to grow at a CAGR of 12.29%, to USD 53.66 billion by 2030.

Bioelectric medicine, a burgeoning field at the intersection of bioengineering, neurology, and advanced medical technologies, harnesses electrical impulses to modulate nervous system activity for therapeutic purposes. Its scope involves developing implantable and non-invasive devices that target specific neural pathways to treat a range of conditions such as chronic pain, epilepsy, depression, and inflammatory diseases. The necessity of bioelectric medicine lies in its potential to offer alternative or complementary solutions to pharmacological treatments, which often have side effects or limited efficacy. Applications span across cardiology, neurology, and pain management, while the end-use scope includes hospitals, specialized clinics, and home healthcare settings, driven by the increasing demand for non-pharmacological treatment options.

KEY MARKET STATISTICS
Base Year [2023] USD 23.83 billion
Estimated Year [2024] USD 26.74 billion
Forecast Year [2030] USD 53.66 billion
CAGR (%) 12.29%

Key growth factors in the bioelectric medicine market include the rising prevalence of chronic diseases, advancements in neuromodulation technologies, and increased investment in research and development. As healthcare systems globally seek efficiency, bioelectric medicine offers cost-effective, targeted therapies, fostering demand. Potential opportunities lie in expanding the scope of wearable bioelectronic devices and personalized treatment protocols. There's significant scope for innovation in developing miniaturized, energy-efficient devices and leveraging artificial intelligence for precision therapy. Collaborations between biomedical firms and academic institutions can catalyze breakthroughs, while regulatory bodies refining approval pathways for medical devices could accelerate market entry.

However, market growth is challenged by high development costs, complex regulatory frameworks, and the need for extensive clinical trials to establish efficacy and safety. Reimbursement issues and limited awareness also pose hurdles. To overcome these challenges, companies should focus on comprehensive clinical evidence generation and proactive stakeholder engagement. Investing in educational campaigns to raise awareness about bioelectric therapy benefits could drive adoption. Ultimately, innovations in bioelectric medicine could dramatically reshape therapeutic strategies across multiple domains, emphasizing the need for ongoing R&D to unlock the sector's full potential and sustain competitive advantage. Collaboration, regulatory navigation, and strategic marketing will be crucial in overcoming barriers and capturing emerging opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bioelectric Medicine Market

The Bioelectric Medicine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing frequency of chronic diseases among population
    • Growing infrastructure expenditure in healthcare sector in developing economies
    • Rising incidences of Parkinson's disease in aging population
  • Market Restraints
    • High costs associated with manufacturing of bioelectric medical devices
  • Market Opportunities
    • Advanced innovations in development of novel bioelectric medicine
    • Rising rate of regulatory approval for bioelectric medicines
  • Market Challenges
    • Stern government rules and regulations for the development and production of medical devices

Porter's Five Forces: A Strategic Tool for Navigating the Bioelectric Medicine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bioelectric Medicine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bioelectric Medicine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bioelectric Medicine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bioelectric Medicine Market

A detailed market share analysis in the Bioelectric Medicine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bioelectric Medicine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bioelectric Medicine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bioelectric Medicine Market

A strategic analysis of the Bioelectric Medicine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bioelectric Medicine Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aleva Neurotherapeutics SA, BioMed Central Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, CEFALY Technology sprl, ElectroCore, Inc., General Electric Company, LivaNova PLC, MED-EL Elektromedizinische Gerate Gesellschaft m.b.H., Medtronic PLC, NeuroSigma, Inc., Nevro Corp., Oticon Medical A/S by Cochlear Ltd, Renishaw PLC, ReShape Lifesciences, Inc., Siemens Healthineers AG, Sonova Holding AG, and Vomaris Innovations, Inc..

Market Segmentation & Coverage

This research report categorizes the Bioelectric Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Cardiac Pacemakers, Cochlear Implants, Deep Brain Stimulators, Implantable Cardioverter Defibrillators, Sacral Nerve Stimulators, Spinal Cord Stimulators, Transcutaneous Electrical Nerve Stimulators, and Vagus Nerve Stimulators.
  • Based on Type, market is studied across Implantable Electroceutical Devices and Noninvasive Electroceutical Devices.
  • Based on Indication, market is studied across Arrhythmia, Chronic Pain, Depression, Epilepsy, Parkinson's Disease, Tremor, and Urinary & Fecal Incontinence.
  • Based on End-User, market is studied across Hospitals and Pharmaceutical Research.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing frequency of chronic diseases among population
      • 5.1.1.2. Growing infrastructure expenditure in healthcare sector in developing economies
      • 5.1.1.3. Rising incidences of Parkinson's disease in aging population
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with manufacturing of bioelectric medical devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Advanced innovations in development of novel bioelectric medicine
      • 5.1.3.2. Rising rate of regulatory approval for bioelectric medicines
    • 5.1.4. Challenges
      • 5.1.4.1. Stern government rules and regulations for the development and production of medical devices
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bioelectric Medicine Market, by Product

  • 6.1. Introduction
  • 6.2. Cardiac Pacemakers
  • 6.3. Cochlear Implants
  • 6.4. Deep Brain Stimulators
  • 6.5. Implantable Cardioverter Defibrillators
  • 6.6. Sacral Nerve Stimulators
  • 6.7. Spinal Cord Stimulators
  • 6.8. Transcutaneous Electrical Nerve Stimulators
  • 6.9. Vagus Nerve Stimulators

7. Bioelectric Medicine Market, by Type

  • 7.1. Introduction
  • 7.2. Implantable Electroceutical Devices
  • 7.3. Noninvasive Electroceutical Devices

8. Bioelectric Medicine Market, by Indication

  • 8.1. Introduction
  • 8.2. Arrhythmia
  • 8.3. Chronic Pain
  • 8.4. Depression
  • 8.5. Epilepsy
  • 8.6. Parkinson's Disease
  • 8.7. Tremor
  • 8.8. Urinary & Fecal Incontinence

9. Bioelectric Medicine Market, by End-User

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Pharmaceutical Research

10. Americas Bioelectric Medicine Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Bioelectric Medicine Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Bioelectric Medicine Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Aleva Neurotherapeutics SA
  • 3. BioMed Central Ltd.
  • 4. Biotronik SE & Co. KG
  • 5. Boston Scientific Corporation
  • 6. CEFALY Technology sprl
  • 7. ElectroCore, Inc.
  • 8. General Electric Company
  • 9. LivaNova PLC
  • 10. MED-EL Elektromedizinische Gerate Gesellschaft m.b.H.
  • 11. Medtronic PLC
  • 12. NeuroSigma, Inc.
  • 13. Nevro Corp.
  • 14. Oticon Medical A/S by Cochlear Ltd
  • 15. Renishaw PLC
  • 16. ReShape Lifesciences, Inc.
  • 17. Siemens Healthineers AG
  • 18. Sonova Holding AG
  • 19. Vomaris Innovations, Inc.